Publications
- IKZF1(plus) Defines a New Minimal Residual Disease-Dependent Very-Poor Prognostic Profile in Pediatric B-Cell Precursor Acute Lymphoblastic Leukemia2018 | Second Faculty of Medicine
- New biological and genetic classification and therapeutically relevant categories in childhood B-cell precursor acute lymphoblastic leukemia2018 | Second Faculty of Medicine
- Intragenic amplification of PAX5: a novel subgroup in B-cell precursor acute lymphoblastic leukemia?2017 | Second Faculty of Medicine
- ETV6/RUNX1-like acute lymphoblastic leukemia: A novel B-cell precursor leukemia subtype associated with the CD27/CD44 immunophenotype2017 | Second Faculty of Medicine
- Prognostic value of rare IKZF1 deletion in childhood B-cell precursor acute lymphoblastic leukemia: an international collaborative study2016 | Second Faculty of Medicine
- Refinement of IKZF1 status in pediatric Philadelphia-positive acute lymphoblastic leukemia2015 | Second Faculty of Medicine
- CD2-positive B-cell precursor acute lymphoblastic leukemia with an early switch to the monocytic lineage2014 | First Faculty of Medicine, Second Faculty of Medicine, Faculty of Physical Education and Sport, Central Library of Charles University
- IKZF1 status as a prognostic feature in BCR-ABL1-positive childhood ALL2014 | Second Faculty of Medicine
- Genomic DNA-based measurable residual disease monitoring in pediatric acute myeloid leukemia: unselected consecutive cohort study2024 | Second Faculty of Medicine
- CD371+ pediatric B-cell acute lymphoblastic leukemia: propensity to lineage switch and slow early response to treatment2024 | Second Faculty of Medicine
Loading network view...